ES2172734T3 - Intermediarios para la preparacion de compuestos benzoheterociclicos. - Google Patents

Intermediarios para la preparacion de compuestos benzoheterociclicos.

Info

Publication number
ES2172734T3
ES2172734T3 ES97120444T ES97120444T ES2172734T3 ES 2172734 T3 ES2172734 T3 ES 2172734T3 ES 97120444 T ES97120444 T ES 97120444T ES 97120444 T ES97120444 T ES 97120444T ES 2172734 T3 ES2172734 T3 ES 2172734T3
Authority
ES
Spain
Prior art keywords
sup
group
halogen atom
rent
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97120444T
Other languages
English (en)
Inventor
Hiraki Ueda
Hisashi Miyamoto
Hiroshi Yamashita
Hitoshi Tone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2172734T3 publication Critical patent/ES2172734T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Abstract

LA PRESENTE INVENCION SE REFIERE A UN COMPUESTO SELECCIONADO DEL GRUPO FORMADO POR LOS COMPUESTOS CON LAS FORMULAS SIGUIENTES: DONDE R SUP,1} ES UN GRUPO CICLOPROPILO QUE PUEDE ESTAR SUSTITUIDO POR 1 A 3 SUSTITUYENTES SELECCIONADOS DEL GRUPO FORMADO POR UN GRUPO ALQUILO INFERIOR Y UN ATOMO DE HALOGENO, UN GRUPO FENILO QUE PUEDE ESTAR SUSTITUIDO POR 1 A 3 SUSTITUYENTES SELECCIONADOS DEL GRUPO FORMADO POR UN GRUPO ALCOXI INFERIOR, UN ATOMO DE HALOGENO Y UN GRUPO HIDROXI SOBRE ANILLO FENILO, UN GRUPO ALQUILO INFERIOR QUE PUEDE ESTAR SUSTITUIDO POR UN ATOMO DE HALOGENO, UN GRUPO ALCANOILOXI INFERIOR O UN GRUPO HIDROXI, UN GRUPO ALQUENILO INFERIOR O UN GRUPO TIENILO; R SUP,2 } ES UN ATOMO DE HALOGENO O UN GRUPO HETEROCICLICO SATURADO O INSATURADO DE 5 A 9 MIEMBROS QUE PUEDE ESTAR SUSTITUIDO; R SUP,3} ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO INFERIOR O UN ATOMO DE HALOGENO; R SUP,3 } ES UN GRUPO DE FORMULA: CH(R SUP,20})SR SUP,21}(R SUP,20} Y R SUP,21} TIENEN EL SIGNIFICADO DEFINIDO DESPUES) OR SUP,3}; R SUP,4} ES UN GRUPO ALQUILO INFERIOR O UN ATOMO DE HALOGENO; R SUP,5} ES UN GRUPO DE FORMULA: 10} (R SUP,10} ES UN GRUPO ALQUILO INFERIOR) O UN GRUPO DE FORMULA: R SUP,6} ES UN GRUPO ALQUILO INFERIOR; R SUP,7} ES UN GRUPO DE FORMULA: -NR SUP,12} SUP,13} (R SUP,12} Y R SUP,13} SON RESPECTIVAMENTE UN GRUPO ALQUILO INFERIOR) O UN GRUPO ALCOXI INFERIOR; R SUP,20} ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO INFERIOR; R SUP,21} ES UN GRUPO ALQUILO INFERIOR; R SUP,25}, R SUP,27} Y R SUP,28} SON RESPECTIVAMENTE UN GRUPO ALQUILO INFERIOR; R SUP,32} ES UN ALQUILO INFERIOR; Y X, X SUP,2}, X SUP,3}, X SUP,4} Y X SUP,7} SON RESPECTIVAMENTE UN ATOMO DE HALOGENO.
ES97120444T 1987-04-16 1988-04-14 Intermediarios para la preparacion de compuestos benzoheterociclicos. Expired - Lifetime ES2172734T3 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP9419887 1987-04-16
JP10235187 1987-04-24
JP10836187 1987-04-30
JP12659887 1987-05-22
JP14954487 1987-06-16
JP17612687 1987-07-14
JP28377687 1987-11-09
JP28710887 1987-11-12

Publications (1)

Publication Number Publication Date
ES2172734T3 true ES2172734T3 (es) 2002-10-01

Family

ID=27572879

Family Applications (3)

Application Number Title Priority Date Filing Date
ES88105959T Expired - Lifetime ES2091180T3 (es) 1987-04-16 1988-04-14 Derivados del acido 7-piperazinil- o 7-morfolino-4-oxo-quinolino-3-carboxilico, su preparacion y su utilizacion como agentes antimicrobianos.
ES93107626T Expired - Lifetime ES2152936T3 (es) 1987-04-16 1988-04-14 Compuestos benzoheterociclicos.
ES97120444T Expired - Lifetime ES2172734T3 (es) 1987-04-16 1988-04-14 Intermediarios para la preparacion de compuestos benzoheterociclicos.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES88105959T Expired - Lifetime ES2091180T3 (es) 1987-04-16 1988-04-14 Derivados del acido 7-piperazinil- o 7-morfolino-4-oxo-quinolino-3-carboxilico, su preparacion y su utilizacion como agentes antimicrobianos.
ES93107626T Expired - Lifetime ES2152936T3 (es) 1987-04-16 1988-04-14 Compuestos benzoheterociclicos.

Country Status (13)

Country Link
US (5) US5591744A (es)
EP (3) EP0823413B1 (es)
JP (2) JPH0696557B2 (es)
KR (2) KR940002113B1 (es)
CN (1) CN1053666C (es)
CY (1) CY2050B1 (es)
DE (4) DE3856434T2 (es)
DK (2) DK170640B1 (es)
ES (3) ES2091180T3 (es)
HK (1) HK128797A (es)
NL (1) NL980011I2 (es)
SA (1) SA97180461A (es)
SG (3) SG49836A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
EP0319906A3 (en) * 1987-12-11 1990-05-02 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US5585491A (en) * 1988-01-25 1996-12-17 Otsuka Pharmaceutical Co., Ltd. Antibacterial agents
AU5123690A (en) * 1989-03-13 1990-09-13 Bristol-Myers Squibb Company 5-substituted-1,4-dihydro-4-oxo-nephthyridine-3-carboxylate antibacterial agents
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
WO1991016327A1 (en) 1990-04-18 1991-10-31 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactams
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
WO1992021659A1 (en) * 1991-05-28 1992-12-10 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
DK0688218T3 (da) * 1993-03-10 2000-03-13 Otsuka Pharma Co Ltd Interleukin-1-inhibitor
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
EP0726269B1 (en) * 1993-10-28 2001-09-05 Kaken Pharmaceutical Co., Ltd. Quinolinecarboxylic acid derivatives and salts thereof
DE4408212A1 (de) * 1994-03-11 1995-09-14 Bayer Ag 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren
DE4431821A1 (de) * 1994-09-07 1996-03-14 Bayer Ag Verfahren zur Herstellung von N-Arylaminoacrylsäurederivaten und die Verwendung so hergestellter N-Arylaminoacrylsäurederivate zur Herstellung von 4-Chinolon-3-carbonsäurederivaten
CA2210007A1 (en) * 1995-01-24 1996-08-01 Yasuo Ito Quinoline carboxylic acid
WO1998023592A1 (fr) * 1996-11-28 1998-06-04 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives d'acide pyridonecarboxylique ou leurs sels, et medicaments contenant ceux-ci en tant que principe actif
DE19652239A1 (de) 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
ATE365152T1 (de) * 1998-09-14 2007-07-15 Otsuka Pharma Co Ltd Verfahren zur herstellung fluorierter benzoesäuren
BR9914158A (pt) * 1998-09-30 2001-06-26 Alcon Lab Inc Composição antibiótica para o tratamento dos olhos, ouvidos e nariz
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
DE19850788A1 (de) * 1998-11-04 2000-05-11 Clariant Gmbh Verfahren zur Herstellung von Trifluorbenzoesäuren
WO2000054811A1 (fr) 1999-03-17 2000-09-21 Daiichi Pharmaceutical Co., Ltd. Compositions medicamenteuses
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
WO2002041891A2 (en) * 2000-11-01 2002-05-30 The Procter & Gamble Company Hiv treatment with benzimidazoles
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US7022712B2 (en) * 2002-03-26 2006-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Solubilization of weak bases
US6664267B1 (en) 2002-05-28 2003-12-16 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
DK1564210T5 (da) 2002-11-20 2010-05-03 Japan Tobacco Inc 4-Oxoquinolinforbindelser og anvendelse deraf som HIV-integraseinhibitorer
KR20120030558A (ko) 2003-09-04 2012-03-28 욱크하트 리미티드 벤조퀴놀리진-2-카복실산 아르기닌 염 사수화물
DK1666477T3 (da) 2003-09-10 2013-07-29 Kyorin Seiyaku Kk 7-(4-trisubstitueret 3-cyclopropylaminomethyl-1- pyrrolidinyl)-quinoloncarboxylsyre-derivat
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
AU2007223260C1 (en) 2006-03-06 2011-02-03 Japan Tobacco Inc. Method for producing 4-oxoquinoline compound
IN2014CN00532A (es) 2006-03-06 2015-04-03 Japan Tobacco Inc
CA2664052C (en) 2006-09-29 2015-01-20 Cipla Limited An improved process for the preparation of temozolomide and analogs
EP2149571A4 (en) * 2007-05-24 2010-09-01 Kyorin Seiyaku Kk MUTILINE DERIVATIVE WITH A RINGED, HETEROCYCLIC AND AROMATIC CARBOXYLIC ACID STRUCTURE IN A SUBSTITUTE AT POSITION 14
WO2009064836A2 (en) * 2007-11-15 2009-05-22 University Of Maryland, Baltimore Kynurenine-aminotransferase inhibitors
US20090270379A1 (en) * 2008-04-23 2009-10-29 Macielag Mark J Quinolone derivatives useful as antibacterial agents
CN106913569B (zh) * 2016-01-04 2022-04-22 广东工业大学 苯酞类化合物在制备抗耐药菌药物中的应用
CN112266326A (zh) * 2020-11-10 2021-01-26 杭州臻挚生物科技有限公司 二氯甲苯硝化物中间体的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604820B2 (ja) * 1979-02-26 1985-02-06 大塚製薬株式会社 キノリンカルボン酸誘導体
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3142856A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-dichlor-5-fluor-benzoylchlorid
JPS58174367A (ja) * 1982-04-07 1983-10-13 Tanabe Seiyaku Co Ltd キノリン誘導体及びその製法
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4577473A (en) * 1983-10-17 1986-03-25 Hoshizaki Electric Co., Ltd. Ice product making machine
JPS60123837A (ja) * 1983-12-09 1985-07-02 Mitsubishi Paper Mills Ltd ハロゲン化銀写真乳剤
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
DE3420770A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(3-oxo-1-piperazinyl)-3-chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3502935A1 (de) * 1984-09-29 1986-04-10 Bayer Ag, 5090 Leverkusen 3-amino-2-benzoyl-acrylsaeurederivate und ein verfahren zu ihrer herstellung
JPS6191183A (ja) * 1984-10-11 1986-05-09 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
DE3441788A1 (de) * 1984-11-15 1986-05-15 Bayer Ag, 5090 Leverkusen Alkyl-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS61205258A (ja) * 1985-03-08 1986-09-11 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体及びその製造方法
US4578473A (en) * 1985-04-15 1986-03-25 Warner-Lambert Company Process for quinoline-3-carboxylic acid antibacterial agents
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
DE3522406A1 (de) * 1985-06-22 1987-01-02 Bayer Ag Verfahren zur herstellung von 1,8-verbrueckten 4-chinolon-3-carbonsaeuren
JPS62469A (ja) * 1985-06-27 1987-01-06 Dainippon Pharmaceut Co Ltd 新規キノロン誘導体、そのエステルおよびその塩
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
EP0230053A3 (en) * 1986-01-17 1988-03-30 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
JPH089597B2 (ja) * 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
GB8612137D0 (en) * 1986-05-19 1986-06-25 Fujisawa Pharmaceutical Co Quinolone compounds
US4771055A (en) * 1986-07-28 1988-09-13 Warner-Lambert Company 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acids
JPS63152318A (ja) * 1986-08-07 1988-06-24 Dainippon Pharmaceut Co Ltd 抗マイコプラズマ剤
GB8702508D0 (en) * 1987-02-04 1987-03-11 Fujisawa Pharmaceutical Co Quinoline compound
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
SI8810667A8 (en) * 1987-04-08 1996-04-30 Chinoin Gyogyszer Es Vegyeszet Anhydride of quinoline carboxylic acid of boron acid and process for their production.
US4766844A (en) * 1987-05-28 1988-08-30 Westinghouse Electric Corp. Robotic tinning station for axial lead electronic components
US4929613A (en) * 1987-08-26 1990-05-29 Warner-Lambert Company Antibacterial agents
DE3811341A1 (de) * 1987-10-09 1989-04-27 Bayer Ag In 7-stellung c-verknuepfte chinolon- und 1,8-naphthyridin-4-on-carbonsaeure und ein verfahren zu ihrer herstellung
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US4945160A (en) * 1988-11-22 1990-07-31 Warner-Lambert Company Preparation of certain 7-substituted quinolones

Also Published As

Publication number Publication date
EP0823413B1 (en) 2002-02-13
CY2050B1 (en) 1998-04-30
DE3856515D1 (de) 2002-03-21
DK101492A (da) 1992-08-13
US5811576A (en) 1998-09-22
EP0287951B1 (en) 1996-07-03
EP0565132A2 (en) 1993-10-13
SA97180461A (ar) 2005-12-03
EP0287951A2 (en) 1988-10-26
DE3856515T2 (de) 2002-08-14
SG49836A1 (en) 1998-06-15
CN1053666C (zh) 2000-06-21
US5591744A (en) 1997-01-07
DK170640B1 (da) 1995-11-20
US5563138A (en) 1996-10-08
HK128797A (en) 1997-09-19
DE3856434T2 (de) 2001-06-13
JP2654537B2 (ja) 1997-09-17
EP0823413A3 (en) 1998-12-09
US5723648A (en) 1998-03-03
DK207688A (da) 1988-10-17
ES2152936T3 (es) 2001-02-16
DK207688D0 (da) 1988-04-15
CN1030237A (zh) 1989-01-11
ES2091180T3 (es) 1996-11-01
DE3855388D1 (de) 1996-08-08
KR880012506A (ko) 1988-11-28
NL980011I2 (nl) 1998-10-01
DK101492D0 (da) 1992-08-13
DE19775083I2 (de) 2001-06-13
JPH07138232A (ja) 1995-05-30
DE3856434D1 (de) 2000-11-30
NL980011I1 (nl) 1998-05-06
US5495020A (en) 1996-02-27
DK171820B1 (da) 1997-06-23
EP0823413A2 (en) 1998-02-11
EP0565132A3 (en) 1994-05-18
DE3855388T2 (de) 1997-02-13
EP0287951A3 (en) 1990-06-13
KR940002113B1 (ko) 1994-03-17
JPH01230558A (ja) 1989-09-14
JPH0696557B2 (ja) 1994-11-30
KR960006145B1 (ko) 1996-05-09
SG101541A1 (en) 2004-01-30
SG97777A1 (en) 2003-08-20
EP0565132B1 (en) 2000-10-25

Similar Documents

Publication Publication Date Title
ES2172734T3 (es) Intermediarios para la preparacion de compuestos benzoheterociclicos.
ES2051719T3 (es) Un procedimiento para producir un compuesto de benzoilurea.
ES2055056T3 (es) Derivados de pirimidopirimidina.
AR000039A2 (es) Compuestos de piridinosulfonamida sustituidos, composiciones herbicidas que los contienen, metodo para preparar estos compuestos y compuestosintermediarios.
ES2063153T3 (es) Amino-4 quinoleinas y naftiridinas, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2052727T3 (es) Composicion herbicida.
ES2028865T3 (es) Procedimiento mejorado para la preparacion de derivados de macrolidas.
CO4520226A1 (es) Compuestos carbociclicos
GB881332A (en) Arylsulphonyl acrylonitriles and compositions containing the same
ES2059416T3 (es) 1,4-dihidropiridina-enantiomeros.
ES2038202T3 (es) Derivados de alcanos trifluorometil insecticidos.
ES2036213T3 (es) Procedimiento para preparar derivados tetrahidroisoquinolin-1-ilicos de acidos carboxilicos.
AR246962A1 (es) Procedimiento para preparar derivados alquilamino-alquilenicos de ciertos 2h-1-benzopiranos.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES2063065T3 (es) Derivados de triazol, procedimiento para su preparacion y composiciones herbicidas que los contienen.
MX174210B (es) Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos
ES2054811T3 (es) Derivados de tetrahidroisoquinolin-2-ilo como antagonistas de tromboxano a2.
ES2080859T3 (es) Alfa-(alquilciclohexiloxi)-beta-alcanoles y composiciones de perfume que contienen los mismos.
ES2054502T3 (es) Esteres del acido 10-(1-hidroxietil)-11-oxo-1-azatriciclo(7.2.0.0(3.8))-undec-2-en-2-carboxilico y un procedimiento para su preparacion.
ES2055804T3 (es) Procedimiento de preparacion de nuevas meta-fenilendiaminas sustituidas con trialcoxi.
ES2028877T3 (es) Un procedimiento para preparar un compuesto heterociclico.
ES2038218T3 (es) Un procedimiento para preparar nuevos derivados de 2-alquilsulfinil-4(3h)-quinazolinona.
ES2038279T3 (es) Metodo para preparar compuestos de tiazol.
ES2074343T3 (es) Nuevas feniletanolamino- y feniletanolaminometil-tetralinas, procedimiento para su preparacion, intermediarios en este procedimiento y composiciones farmaceuticas que los contienen.
ES2001006A4 (es) Compuestos sustituidos de 2,6-piridina sustituida

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 823413

Country of ref document: ES